Ethyl 4-(4-fluorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 90%, 1g

N,N-dimethyl-4-(pyrazin-2-yl)aniline, 95.0%, 1g

N6-Benzoyladenosine, 95.0%, 100g

METHYL 4-ACETYL-2-AMINOBENZOATE, 95%, 1g

(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate, 97.0%, 250mg

Dimethyl (2-oxo-3-phenoxypropyl)phosphonate, 95.0%, 25g

(3-(2-Methoxy-2-oxoethyl)phenyl)boronic acid, 95.0%, 1g

(R)-4-Methyl-1,2,3,4-tetrahydroisoquinoline, 95.0%, 100mg

Diclorometano, mínimo 99,5 %, para síntesis, 100 ml, envase de vidrio

N,N'-BIS(BENZYLOXYCARBONYL)GUANIDINE, 95.0%, 1g

Diethyl Benzylmalonate>98.0%(GC)25mL

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-methoxy-4-oxobutanoic acid, 97%, 1g

(1R,2R)-2-(4-bromobenzoyl)cyclopentane-1-carboxylic acid, 98%, 100mg